Last $1.27 USD
Change Today -0.04 / -3.05%
Volume 2.1M
AMRN On Other Exchanges
Symbol
Exchange
Frankfurt
As of 4:30 PM 11/24/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Paul E. Huff

Chief Commercial Officer and Senior Vice President, Amarin Corporation plc
AgeTotal Calculated CompensationThis person is connected to 9 board members in 1 different organizations across 2 different industries.

See Board Relationships
55--

Background*

Mr. Paul E. Huff has been Chief Commercial Officer of Amarin Corporation plc since 2010 and serves as its Senior Vice President. Mr. Huff served as Vice President of Business Development and Vice President of Marketing at Reliant Pharmaceuticals, Inc. and played a pivotal role in the launch and successful commercialization of Lovaza. He joined Reliant in February 2004 and has over 25 years of experience in the pharmaceutical industry, primarily in cardiovascular marketing. ...

Read Full Background

Corporate Headquarters*

2 Pembroke House
Dublin, Co. Dublin 2

Ireland

Phone: 353 1 669 9020
Fax: --

Board Members Memberships*

Director

Education*

BS
University of Maryland

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AMRN:US $1.27 USD -0.04

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Richard F. Pops Chairman of the Board and Chief Executive Officer
Alkermes plc
$810.2K
Jean-Jacques Bienaimé Chief Executive Officer and Director
BioMarin Pharmaceutical Inc.
$868.8K
Leonard S. Schleifer M.D., Ph.D.Co-Founder, Chief Executive Officer, President, Executive Director and Ex Officio Member of Technology Committee
Regeneron Pharmaceuticals, Inc.
$3.1M
Ariel Katz Chief Executive Officer and President
Enzymotec Ltd.
--
Bruce C. Cozadd Co-Founder, Executive Chairman and Chief Executive Officer
Jazz Pharmaceuticals Public Limited Company
$771.2K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AMARIN CORP PLC -ADR, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.